JP2014518252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518252A5 JP2014518252A5 JP2014517915A JP2014517915A JP2014518252A5 JP 2014518252 A5 JP2014518252 A5 JP 2014518252A5 JP 2014517915 A JP2014517915 A JP 2014517915A JP 2014517915 A JP2014517915 A JP 2014517915A JP 2014518252 A5 JP2014518252 A5 JP 2014518252A5
- Authority
- JP
- Japan
- Prior art keywords
- cough
- condition
- respiratory
- oral composition
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010011224 Cough Diseases 0.000 claims 48
- 239000000203 mixture Substances 0.000 claims 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 12
- 230000000241 respiratory effect Effects 0.000 claims 9
- 230000000954 anitussive effect Effects 0.000 claims 8
- 208000024891 symptom Diseases 0.000 claims 8
- 201000010099 disease Diseases 0.000 claims 7
- 206010061218 Inflammation Diseases 0.000 claims 6
- 230000004054 inflammatory process Effects 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 4
- 206010060954 Abdominal Hernia Diseases 0.000 claims 3
- 206010013952 Dysphonia Diseases 0.000 claims 3
- 206010019909 Hernia Diseases 0.000 claims 3
- 208000010473 Hoarseness Diseases 0.000 claims 3
- 208000007101 Muscle Cramp Diseases 0.000 claims 3
- 206010068319 Oropharyngeal pain Diseases 0.000 claims 3
- 208000031481 Pathologic Constriction Diseases 0.000 claims 3
- 201000007100 Pharyngitis Diseases 0.000 claims 3
- 206010036790 Productive cough Diseases 0.000 claims 3
- 208000037656 Respiratory Sounds Diseases 0.000 claims 3
- 208000027790 Rib fracture Diseases 0.000 claims 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 3
- 208000005392 Spasm Diseases 0.000 claims 3
- 206010047700 Vomiting Diseases 0.000 claims 3
- 206010047924 Wheezing Diseases 0.000 claims 3
- 208000013116 chronic cough Diseases 0.000 claims 3
- 230000013872 defecation Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 208000017574 dry cough Diseases 0.000 claims 3
- 230000006870 function Effects 0.000 claims 3
- 206010022437 insomnia Diseases 0.000 claims 3
- 230000027939 micturition Effects 0.000 claims 3
- 208000024794 sputum Diseases 0.000 claims 3
- 210000003802 sputum Anatomy 0.000 claims 3
- 230000036262 stenosis Effects 0.000 claims 3
- 208000037804 stenosis Diseases 0.000 claims 3
- 206010042772 syncope Diseases 0.000 claims 3
- 210000001186 vagus nerve Anatomy 0.000 claims 3
- 230000008673 vomiting Effects 0.000 claims 3
- 206010003645 Atopy Diseases 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 206010008685 Chondritis Diseases 0.000 claims 2
- 208000000059 Dyspnea Diseases 0.000 claims 2
- 206010013975 Dyspnoeas Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims 2
- 206010070488 Upper-airway cough syndrome Diseases 0.000 claims 2
- 239000003434 antitussive agent Substances 0.000 claims 2
- 229940124584 antitussives Drugs 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000011109 contamination Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 210000000613 ear canal Anatomy 0.000 claims 2
- 230000002526 effect on cardiovascular system Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000003172 expectorant agent Substances 0.000 claims 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 2
- 230000002650 habitual effect Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 230000007383 nerve stimulation Effects 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- 230000000391 smoking effect Effects 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- 206010008479 Chest Pain Diseases 0.000 claims 1
- 206010010719 Conjunctival haemorrhage Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims 1
- 206010038678 Respiratory depression Diseases 0.000 claims 1
- 206010038687 Respiratory distress Diseases 0.000 claims 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 claims 1
- 206010039897 Sedation Diseases 0.000 claims 1
- 206010041349 Somnolence Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims 1
- 208000026317 Tietze syndrome Diseases 0.000 claims 1
- 206010044565 Tremor Diseases 0.000 claims 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- 239000000850 decongestant Substances 0.000 claims 1
- 229940124581 decongestants Drugs 0.000 claims 1
- 208000002173 dizziness Diseases 0.000 claims 1
- 206010013781 dry mouth Diseases 0.000 claims 1
- 230000003628 erosive effect Effects 0.000 claims 1
- 230000003419 expectorant effect Effects 0.000 claims 1
- 229940066493 expectorants Drugs 0.000 claims 1
- 201000005917 gastric ulcer Diseases 0.000 claims 1
- 229940066491 mucolytics Drugs 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 230000000631 nonopiate Effects 0.000 claims 1
- 229940127240 opiate Drugs 0.000 claims 1
- 210000000578 peripheral nerve Anatomy 0.000 claims 1
- 230000001144 postural effect Effects 0.000 claims 1
- 230000000506 psychotropic effect Effects 0.000 claims 1
- 230000036280 sedation Effects 0.000 claims 1
- 230000036299 sexual function Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- 229960004559 theobromine Drugs 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1111485.7 | 2011-07-05 | ||
| GBGB1111485.7A GB201111485D0 (en) | 2011-07-05 | 2011-07-05 | Drug composition and its use in therapy |
| PCT/GB2012/050816 WO2013004999A1 (en) | 2011-07-05 | 2012-04-13 | Drug combinations and uses in treating a coughing condition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017212821A Division JP2018048189A (ja) | 2011-07-05 | 2017-11-02 | 薬剤の組合せ、および咳嗽状態の治療における使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014518252A JP2014518252A (ja) | 2014-07-28 |
| JP2014518252A5 true JP2014518252A5 (enExample) | 2015-05-21 |
Family
ID=44512137
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517915A Pending JP2014518252A (ja) | 2011-07-05 | 2012-04-13 | 薬剤の組合せ、および咳嗽状態の治療における使用 |
| JP2017212821A Pending JP2018048189A (ja) | 2011-07-05 | 2017-11-02 | 薬剤の組合せ、および咳嗽状態の治療における使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017212821A Pending JP2018048189A (ja) | 2011-07-05 | 2017-11-02 | 薬剤の組合せ、および咳嗽状態の治療における使用 |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP2729136A1 (enExample) |
| JP (2) | JP2014518252A (enExample) |
| KR (1) | KR101676454B1 (enExample) |
| CN (1) | CN103648488A (enExample) |
| AU (2) | AU2012280019B2 (enExample) |
| BR (1) | BR112014000159A2 (enExample) |
| CA (1) | CA2840793A1 (enExample) |
| GB (1) | GB201111485D0 (enExample) |
| MX (1) | MX2014000129A (enExample) |
| RU (2) | RU2016101054A (enExample) |
| WO (1) | WO2013004999A1 (enExample) |
| ZA (1) | ZA201400010B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
| GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
| GB201014391D0 (en) * | 2010-08-27 | 2010-10-13 | Biocopea Ltd | Drug composition and its use in therapy |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| AU2013388034B2 (en) | 2013-04-30 | 2019-08-15 | Aspeya US Inc. | Dry powder formulations and methods of use |
| US20170368150A1 (en) * | 2014-09-08 | 2017-12-28 | Gotham Biopharmaceuticals, Inc. | Methods of treating pulmonary sarcoidosis |
| CN104436176A (zh) * | 2014-11-17 | 2015-03-25 | 华东理工大学 | 一种基于上呼吸道感染及肺炎用的新型生物抗菌喷雾剂 |
| CA3076353A1 (en) | 2017-09-22 | 2019-03-28 | Otitopic Inc. | Dry powder compositions with magnesium stearate |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| CN109793823A (zh) * | 2017-11-17 | 2019-05-24 | 中国科学院大连化学物理研究所 | 一种外用止咳平喘软膏剂及其制备方法 |
| CN112703000B (zh) * | 2018-07-23 | 2024-05-31 | 特雷维治疗股份有限公司 | 慢性咳嗽、呼吸急促和呼吸困难的治疗 |
| CN113993523A (zh) | 2019-04-17 | 2022-01-28 | 指南针探路者有限公司 | 用赛洛西宾治疗抑郁症和其他各种病症 |
| US20240122934A1 (en) * | 2019-10-16 | 2024-04-18 | University Of South Florida | Compositions and methods of treatment for inhibiting capillary tube regression |
| US12409173B2 (en) * | 2019-12-31 | 2025-09-09 | The Trustees Of Indiana University | Repurposing FDA-approved drugs as a novel cancer therapeutic avenue through inhibition of PRMT5 |
| AU2021206252A1 (en) | 2020-01-10 | 2022-07-28 | Trevi Therapeutics, Inc. | Methods of administering nalbuphine |
| US11628165B1 (en) * | 2020-03-25 | 2023-04-18 | Helen Feng | Method of boosting immune system against viral infection |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4756911A (en) | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| US20020009478A1 (en) * | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
| JP2002363072A (ja) * | 2001-04-03 | 2002-12-18 | Taisho Pharmaceut Co Ltd | 鎮咳用組成物 |
| JP2003081821A (ja) * | 2001-09-12 | 2003-03-19 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| JP4377564B2 (ja) * | 2002-05-02 | 2009-12-02 | ロート製薬株式会社 | 内服用組成物 |
| US6979689B2 (en) * | 2002-12-20 | 2005-12-27 | Pediamed Pharmaceuticals, Inc. | Compositions and methods for treating upper respiratory congestion |
| US20050152967A1 (en) * | 2003-03-28 | 2005-07-14 | Pfab, Lp | Dynamic variable release |
| BRPI0506983A (pt) | 2004-01-20 | 2007-07-03 | Allergan Inc | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico |
| US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| JP4195895B2 (ja) * | 2006-04-04 | 2008-12-17 | 小林製薬株式会社 | 吐出装置を備えた容器に収容される経口投与用液体医薬製剤 |
| US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
| US20110008437A1 (en) | 2009-04-20 | 2011-01-13 | Altman Gregory H | Silk Fibroin Hydrogels and Uses Thereof |
| GB0919893D0 (en) * | 2009-11-13 | 2009-12-30 | Biocopea Ltd | Drug composition and its use in therapy |
| GB0919889D0 (en) * | 2009-11-13 | 2009-12-30 | Biocopea Ltd | Drug composition and its use in therapy |
| GB201014391D0 (en) * | 2010-08-27 | 2010-10-13 | Biocopea Ltd | Drug composition and its use in therapy |
| GB0921803D0 (en) * | 2009-12-14 | 2010-01-27 | Biocopea Ltd | Drug composition and its use in therapy |
| GB0921805D0 (en) * | 2009-12-14 | 2010-01-27 | Biocopea Ltd | Drug composition and its use in therapy |
| GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
| UA47594U (uk) * | 2009-09-17 | 2010-02-10 | Игорь Викторович Трутаев | Комбінований засіб для лікування та профілактики захворювань дихальних шляхів |
| JP5815226B2 (ja) * | 2009-11-30 | 2015-11-17 | 興和株式会社 | ロキソプロフェンを含有する医薬組成物 |
-
2011
- 2011-07-05 GB GBGB1111485.7A patent/GB201111485D0/en not_active Ceased
-
2012
- 2012-04-13 RU RU2016101054A patent/RU2016101054A/ru unknown
- 2012-04-13 AU AU2012280019A patent/AU2012280019B2/en not_active Ceased
- 2012-04-13 JP JP2014517915A patent/JP2014518252A/ja active Pending
- 2012-04-13 KR KR1020147002930A patent/KR101676454B1/ko not_active Expired - Fee Related
- 2012-04-13 CA CA2840793A patent/CA2840793A1/en not_active Abandoned
- 2012-04-13 MX MX2014000129A patent/MX2014000129A/es unknown
- 2012-04-13 RU RU2014103787/15A patent/RU2014103787A/ru unknown
- 2012-04-13 EP EP12716069.5A patent/EP2729136A1/en not_active Withdrawn
- 2012-04-13 EP EP17177202.3A patent/EP3251665A1/en not_active Withdrawn
- 2012-04-13 BR BR112014000159-6A patent/BR112014000159A2/pt not_active IP Right Cessation
- 2012-04-13 WO PCT/GB2012/050816 patent/WO2013004999A1/en not_active Ceased
- 2012-04-13 CN CN201280033545.1A patent/CN103648488A/zh active Pending
-
2014
- 2014-01-06 ZA ZA2014/00010A patent/ZA201400010B/en unknown
-
2016
- 2016-11-09 AU AU2016256741A patent/AU2016256741A1/en not_active Abandoned
-
2017
- 2017-11-02 JP JP2017212821A patent/JP2018048189A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014518252A5 (enExample) | ||
| RU2014103787A (ru) | Комбинации лекарственных средств и их применение в лечении состояния, сопровождающегося кашлем | |
| JP2005506370A5 (enExample) | ||
| RU2005137165A (ru) | Применение соединения для лечения нарушений сна | |
| JP6753860B2 (ja) | リルゾールの舌下製剤 | |
| JP2011503045A (ja) | Ｃｒｔｈ２拮抗化合物の使用 | |
| JP2017528507A5 (enExample) | ||
| JP2006523216A5 (enExample) | ||
| JP2006511502A (ja) | 睡眠時無呼吸の薬理学的処置 | |
| JP2007533687A5 (enExample) | ||
| US20100204205A1 (en) | Tolerability of mirtazapine and a second active agent by using them in combination | |
| JP2009537553A5 (enExample) | ||
| JP2006507225A5 (enExample) | ||
| JP2016512817A5 (enExample) | ||
| EP2964185B1 (en) | Preparations for the treatment of sleep-related respiratory disorders | |
| US10682343B2 (en) | Snoring treatment | |
| CN100558358C (zh) | 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用 | |
| JP2011500589A5 (enExample) | ||
| KR20150011379A (ko) | 옥시부티닌 투여를 위한 방법 및 조성물 | |
| US11744833B2 (en) | Pharmaceutical compositions and methods for treatment of insomnia | |
| JP2008516909A5 (enExample) | ||
| EP4478887A1 (en) | Novel pharmaceutical compositions and methods for treatment of insomnia | |
| JP5634529B2 (ja) | 強迫性障害（ｏｃｄ）処置用の薬剤の製造のためのアゴメラチンの使用 | |
| JP2005511632A5 (enExample) | ||
| WO2006115135A1 (ja) | 過敏性腸症候群治療剤 |